Numinus Wellness Inc.

TSX:NUMI.TO

0.035 (CAD) • At close September 6, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) CAD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q3
Revenue 4.34955.9466.1316.0275.3555.6684.1770.7410.7860.790.4910.5620.2320.2290.2710.2160.2590.1340.0220.0350.0220.0280
Cost of Revenue 3.683.7393.7974.3223.9463.2483.2932.8610.560.5570.7390.4590.5780.2910.2670.4290.1410.1550.0680.0890.1020.080.0890
Gross Profit 0.6681.2612.1491.8092.0812.1072.3761.3160.1810.2290.0510.032-0.015-0.06-0.038-0.1580.0760.1040.066-0.067-0.066-0.058-0.0610
Gross Profit Ratio 0.1540.2520.3610.2950.3450.3930.4190.3150.2440.2910.0650.065-0.028-0.258-0.166-0.5840.350.4030.493-2.991-1.868-2.641-2.2160
Reseach & Development Expenses 0.0040.0060.0130.20.2670.2760.4250.5730.5070.4750.3310.360.6310.3210.090.1490.04000.0630.0260.0330.0270
General & Administrative Expenses 4.455.9965.7426.8918.098.0357.5149.1925.4826.3564.1374.2983.0962.8351.463.491.0130.7610.8362.1781.0681.0320.7880.075
Selling & Marketing Expenses 0.1710.3350.210.4230.3810.4640.7240.560.4420.430.7610.1860.9680.8010.2690.5750.210.0250.0060.0230.0730.060.0330.004
SG&A 4.626.3315.9527.3138.4728.4988.2389.7535.9246.7854.8984.4844.0643.6371.7294.0661.2230.7850.8422.2011.1411.0920.9850.071
Other Expenses -1.032-0.017-0.022-0.6050.0030.010.0610.6280.1730.129-0.031-0.0910.0080.0110.0370.065-0.0050000000
Operating Expenses 4.6256.3376.3147.8829.1719.29.07810.9546.6047.3895.285.0524.7714.0261.914.1661.3460.8810.9572.5731.2481.1961.0820.108
Operating Income -3.956-5.076-4.185-6.673-7.084-7.083-6.641-9.191-6.423-7.16-5.229-5.111-4.779-4.23-1.948-4.332-1.277-0.777-0.891-2.627-1.315-1.254-1.144-0.071
Operating Income Ratio -0.91-1.015-0.704-1.088-1.175-1.323-1.172-2.2-8.667-9.108-6.623-10.412-8.503-18.273-8.5-15.983-5.906-2.995-6.631-117.708-37.091-57.035-41.2310
Total Other Income Expenses Net -1.168-0.878-0.075-3.126-0.004-0.0080.591-14.874-0.445-0.51-0.079-2.722-0.001-0.1330.037-0.21-1.981-0.005-0.014-0.884-0-0.013-0.012-0.037
Income Before Tax -5.124-5.954-4.406-9.386-7.28-7.293-6.297-24.716-7.008-7.838-5.354-7.783-4.824-4.238-1.929-4.591-3.306-0.792-0.905-3.539-1.327-1.267-1.156-0.108
Income Before Tax Ratio -1.178-1.191-0.741-1.531-1.208-1.362-1.111-5.917-9.457-9.97-6.781-15.854-8.583-18.306-8.416-16.939-15.288-3.054-6.733-158.576-37.429-57.631-41.6760
Income Tax Expense 0.631-00.147-0.0480.0090.039-0.5315.2870.4450.510.046-0.050.0440.030.0560.1310.0490.0150.006-0.0670.01200.080
Net Income -5.755-5.954-4.406-9.338-7.289-7.331-6.297-24.682-7.008-7.838-5.354-7.783-4.824-4.238-1.929-4.591-3.306-0.792-0.911-3.539-1.327-1.267-1.076-0.108
Net Income Ratio -1.323-1.191-0.741-1.523-1.209-1.369-1.111-5.909-9.457-9.97-6.781-15.854-8.583-18.306-8.416-16.939-15.288-3.054-6.779-158.576-37.429-57.631-38.7970
EPS -0.022-0.023-0.017-0.035-0.028-0.028-0.024-0.11-0.033-0.038-0.026-0.038-0.025-0.028-0.017-0.048-0.035-0.016-0.017-0.048-0.019-0.026-0.0150
EPS Diluted -0.022-0.023-0.017-0.035-0.028-0.028-0.024-0.11-0.033-0.038-0.026-0.038-0.025-0.028-0.017-0.048-0.035-0.016-0.017-0.048-0.019-0.026-0.0150
EBITDA -3.534-4.468-3.538-6.001-6.344-6.358-5.943-8.456-6.131-6.905-5.006-4.86-4.573-3.956-1.769-4.093-1.031-0.676-0.776-2.426-1.212-1.183-1.073-0.071
EBITDA Ratio -0.813-0.894-0.595-0.979-1.053-1.187-1.048-2.024-8.274-8.784-6.339-9.901-8.136-17.087-7.72-15.103-4.767-2.605-5.771-108.701-34.2-53.807-38.6740